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ABSTRACT
This work employs organic and polymer synthesis to construct a novel polymeric
contrast agent for the application of mild traumatic brain injury in which affects so many
lives not only in the united states by also internationally as well. Our approach to
tackling this issue is to take advantage of diffuse axial injury and the phenomena of the
fluctuation of free calcium ions after trauma occurs. We aim to take advantage of
chelation chemistry. For this, we carefully construct a polymeric contrast agent that
contains free carboxylic acid groups that can alternate between coordinating with
gadolinium species in our contrast agent and the free calcium ions. In this way, what is
hopefully obtained is an ion response polymeric contrast agent that can be for medical
imaging purposes.
The first proposed idea of our work involves simple free radical polymerization
containing carboxylic acids on the backbone of the polymer and a conjugated chelating
component, which is vastly like ProHance(gadoteridol) a commercially available contrast
agent. The polymer contrast agents were then successfully characterized using nuclear
magnetic resonance (NMR) and Fourier transform inferred spectroscopy (FTIR) for
structural analysis. Furthermore, magnetic resonance imaging (MRI) imagining
properties determined using a 3 T coil, and the result were recorded and analyzed.
While in later works, a more know calcium chelator 1,2 bis(aminophenoxy)ethane-N, N,
N′, N′-tetraacetic acid (BAPTA) is latter introduced as well as more advanced synthetic
techniques in hopes better to improve the first design of the original concept.
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CHAPTER ONE
Introduction and review of literature
1.1 Principals of magnetic resonance imaging
Magnetic resonance imaging (MRI) has emerged as one of the most versatile medical
imaging techniques, providing a pathway for non-evasive imaging techniques. In
essence, it takes advantage of the hydrogen nucleus due to the high natural
abundance of the H1 of 99.9844% and deuterium 0.0156% (1). MRI is a great practical
application for fundamental principles. When water protons in the body are
introduced to a magnetitic field, the magnetic dipole of the protons align in the
direction of the magnetic field, as shown in figure 1.1 (2).

Figure 1.1) Alignment of atomic nuclei by magnetic field then applied radio pulse (2).

The radio pulse also, shown in figure 1.1, affect the equilibrium position of the
protons, which gives rise to two different types of relaxation mechanisms, spin-lattice
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(T1) and spin-spin relaxation(T2). T1 is the equilibration of the net magnetization from
the direction of the magnetic field, as shown in figure 1.2. T2 is the dephasing of the
magnetic vector along the X-Y plane perpendicular to the course of the magnetic field.

Figure 1.2) Schematic of both T1 and T2 relaxation mechanisms
Systemic radio pulse sequences by changing Inversion recovery (IR) times and
reputation time (TR) sequences generate T1 and T2 maps. In most cases for T1, a range
of IR times is picked, followed by a constant short TR on the vary from 1-5 seconds by
keeping the TR short it limits the T2 interaction. For T2 measurements, a series of echo
time(TE’s) are picked, followed by a long TR to show T2 interactions (3). Moreover, T1
and T2 relaxation vary from the environment. For example, the cerebral spinal fluid
will have a different T1 and T2 as opposed to the white or grey matter in the brain.
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1.2 MRI contrast agents
The development of contrast agents enhanced MRI resolution, MRI contrast agents
are widely used to enhance T1 or T2 times. Typically, gadolinium-based chelates are
used T1 contrast in clinics (4). The reason for this is that gadolinium consists of seven
unpaired electrons in the outer shell of the metal ion giving rise to its unique magnetic
properties. However, T2 typically uses iron oxide nanoparticles because they disrupt
the magnetic field locally, causing inhomogeneities in the applied magnetic field flux
and influencing T2 the relaxation mechanism(5). The T1 mechanism works with the
interaction of the water protons with either the inner or outer sphere diameter
forcing the relaxation of the water proton.

Figure 1.3) Schematic of gadolinium chelate interaction with water(6).
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Moreover, this chelation is not stationary; water molecules constantly move in and
out of the inner and outer spheres, thus making the metal complex and proton
interaction a dynamic process. In most common contrast agents, approximately 60%
of the interaction is from the inner sphere, while the other 40% is contributed to the
outer sphere(7). Either T1 or T2 contrast work in such a way to reduce T1 times or T2
times, thus providing a contrast on T1 or T2 weighted images, respectively.
Furthermore, the T1 and T2 can be calculated based on paramagnetic ion shown in
equation 1. Where T1, obs is the observed relaxation time, T1,d is the relaxation time of
background, R1 is the relaxation rate of contrast agent and finally [Gd] is the
concentration of gadolinium

(Equation 1.1)

Equation 1.1

demonstrates that there is a linear relationship between the

concentration of gadolinium and the observe relaxation time. Certain contrast agents
already approved for clinical use have their values well defined, such as
Gadovist(gadobutrol), which has a relxativity of both R1 and R2 of about 3.5 and 4.0,
respectively. The relxativity of the contrast agent is not only dependent on the ligand
of the metal ion, but also on the field strength that is applied. In general, the relxativity
constant r1 decreases as field strength goes up(8, 9). Furthermore, this is
predominantly because of the shift in the Larmor frequency, which is proportional to
the magnetic field(4, 10, 11). More recently, since the success of Food drug
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administration (FDA) approved contrast agents. Attention has turned to the use of
contrast agents to target specific physiological events in the body, such as (Na+, K+,
Mg2+, and Ca2+) (12).

Table 1.1) Table of different relaxivities at different magnetic fields and different
contrast agents. (13)

1.3 Traumatic Brain Injury (TBI) and the physiological importance of calcium
In recent years TBI has been a growing concern, with the majority TBI on sportsrelated brain injuries. Yearly, about 2.5 million people in the United States are affected
by TBI, along with 75 to 90 % of theses TBI injuries to be mild traumatic brain injuries
(14). Moreover, there is not an adequate way to successfully diagnose or quantify the
trauma the brain has received; instead, the treatment relies on the symptoms
displayed by the subject. Testing mTBI is subjective and that this often causes miss
diagnoses. Moreover, this leads to a degree of uncertainty in the severity of the
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trauma(15). Calcium plays an essential role in brain injury as well as other neurological
events and diseases. Fluctuations of calcium levels in the brain after trauma causes
elevated levels of calcium in the intercellular and lowering calcium levels in the
extracellular region (16). The phenomenon(diffuse axel injury) of the transport from
calcium from the extracellular region of the brain to the intracellular region, where
there is stretching and tearing of the axonal neurons(17). Furthermore, changes from
calcium homeostasis can also have an impact on memory loss and other neurological
dysfunctions(18). Studies indicate that current calcium levels existing in the
extracellular region is in the range of about 0.1 mM to about 1.2 mM for what is
considered proper calcium homeostasis (19). Moreover, the range of normal
intracellular calcium levels is on the order of about 50 to 100 nM (20). Therefore, the
level of calcium levels between both the intercellular region and extracellular region
varies significantly, causing a high gradient between them. Approximately the
extracellular region is about 10000 times more. Providing that at the time of injury,
there is significant diffusion between the two regions, which in the end causes
neurological cell death. As calcium levels flood the intracellular region, the is a
measurable drop in the extracellular region after trauma was induced (18). Thus, a
contrast agent that can detect changes in calcium is essential for the nature of this
phenomenon. As mentioned above, calcium is vital for neurological events. As
described in this study but also in other physiological areas as well, such as the heart.
Ideally, it becomes the goal of this work to be able to generate contrast agents with
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known material properties, quantification of certain psychological events. Helping to
improve the lives of patients as well as further an understanding of the human body
as well.
1.4 Ion sensing contrast agents
Ion sensing contrast agents are growing in development with the promise that they
will help target specific ions that change during neurological events. A few of these
novel contrast agents are still currently under construction. For example, a contrast
agent that proved sensitive to zinc selectivity is presently being developed (21).

Figure 1.4) Gadolinium coordinatized complex showing association and dissociation
equilibrium with the presence of zinc ions. (21)
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In which they have developed an organic molecule that was then further chelated to
gadolinium. Figure 1.4 displays the structural conformation that occurs, then zinc is
introduced into the system and thus changing the relaxivity of the contrast agent.
Indicating that this complex then demonstrated a high affinity for Zn ions(21).

Figure 1.5) Graph of equivalence of ZnCl2 as a function of relaxivity. (21)

The plot of the R1 vs. ZnCl2 graph that demonstrates change indicating a dependence
on zinc ions, as shown in figure 1.5. The graph shows that as the amount of ZnCl2, the
relaxivity starts to decrease until it begins to plateau off at one equivalent of ZnCl2.The
graph indicates a change in relaxivity until one molar ratio. Furthermore, other
contrast agents in development show a dependence on calcium showed a calcium
dependence using calmodulin and iron oxide nanoparticles(22). Thus, predominately
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making it a T2 contrast agent instead of T1. However, the calmodulin showed a
dependence of around 500 μM(22).
Furthermore, one of the more recent developments was the use and modification of
1,2 bis(aminophenoxy)ethane-N, N, N′, N′-tetraacetic acid (BAPTA) as a way to
synthesis a contrast agent that is effective and sensitive to calcium ions (23). As
mentioned in the article, they successfully produced a manganese contrast agent that
demonstrated a high affinity to calcium ions. They created the contrast agent by
taking BAPTA and modifying it through nitration then a reduction to put a secondary
amine successfully. Moreover, in figure 1.6, this gadolinium complex demonstrates its
selectivity of Ca+2 over Mg2+ ions, which is one of the competing ions that is also a
presence in the brain. The plot described in figure 1.6 displays relaxivity vs. a metal
concentration (Mg+2or Ca+2). The two curves suggest that contrast dye is more
efficient with the addition of calcium over magnesium, showing a change in relaxivity
as the concentration of metal ions change. It is indicating about a 25% change in
relaxivity at peak concentrations of metal ion levels. The contrast agent created could
be used as a potential method to detect calcium in the brain.
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Figure 1.6) Graph of relaxivity of changes as a function of calcium and magnesium free ions (21)
This idea of ion growing contrast agents is growing, and it is one of the goals of this work
to expand this idea of ions sensitive contrast agents to incorporate polymers instead of
just small molecules.
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Figure 1.7) Figure showing Calcium interaction with BAPTA conjugated MRI
contrast structure (21)
More interestingly, if we make a comparison of carboxylic acid ratios, we can try to
understand what is happening with the carboxylic acid and calcium interaction. In a
theoretical scenario, it would take one free calcium ion per 2 carboxylic acid giving a
max ratio of 0.5 [Ca]/[COOH]. When the ratio of [Ca]/[COOH] was examined in
Angelovski et al., work his macromolecule seemed to demonstrate that the shortest
T1 time being around 2 [Ca]/[polymer concentration] or about 1 [Ca]/[COOH] (24).
Looking back at other literature examples such as the publication of the work of a
Barandov et al. showed his macromolecules has a [Ca]/[COOH] of around 1 to 1.5 both
demonstrating where the onset where his relaxivity curve starts to behave
asymptotically (25).

11

Figure 1.8) graph showing calcium interaction with BAPTA conjugated MRI contrast
structure (22)

1.5 Fundamentals of chelation chemistry
An understanding of chelation chemistry is necessary for the creation of these
contrast agents. When examining chelates, there are three aspects the central metal
atom, the chelating molecules, and the nature of the interaction between the
chelating molecules and the central metal species. First, the metal ion forms complex
bonds to its neighboring atoms allowing acceptance from an electron pair and
allowing it to create a metal-ligand bond (26). This interaction with neighboring atoms
attributes to the solubility of the metal ion and a reduction in toxicity from the metal
ion(27).
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Moreover, it is this interaction that allows contrast agents to become possible. For
example, gadolinium in its free ion form is extremely toxic; however, in typical FDA
approved contrast agents, the predominate chelator to this is some derivative of
diethylenetriamine pentaacetic acid (DTPA). This chelation mechanism dramatically
reduces the toxicity to the human body but taking up coronating sites that could
interact with biological matter (28). Calcium chelators has been an interest in this
work for the described in 1.3. One of the first calcium chelators is ethylene glycol-bis
(β-aminoethyl ether)-N, N, N′, N′-tetraacetic acid (EGTA). However, it had some
limitations, such as the kinetics of calcium bindings and the sensitivity to pH. To
address some of the issues that EGTA had, a chemical company named Tsien
developed BAPTA, which showed much high selectivity of magnesium, lower pH
sensitivity, and higher rates of calcium association and dissociation (29).
Most literature displayed shows four carboxylic acids from calcium-sensitive
chelators. Perhaps this is likely due to a combination of more chelation elements and
the structural conformation in space that can cause the orientation of compound to
arrange itself around the metal species. In this way, the organics molecule acts as a
change keeping the inorganic component at the center of the compound.
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Figure 1.9) calcium interaction dye interaction with BAPTA dye

Its the kinetics moderates the effectiveness of chelation. The faster the associates and
dissociation of calcium, the more effective the chelator is. Essentially the higher the
equilibrium constant in equation 2 means that the [calcium-ligand] concentration is
higher, thus favoring metal-ligand complex coordination over the presence of free
calcium. Equation 2 defines the chelation strength of the organic compound to the
free calcium. Where K is the equilibrium constant and [calcium-ligand] is the
concentration of calcium bound to the ligand, [free-calcium] is the Ca+2 ions in solution
and [ligand] is the concentration of unbound ligands.
K = [calcium-ligand]/[free-calcium][ligand] (equation 1.2)

Furthermore, this constant is greatly dependent on the pH of the system. This work
focuses on gadolinium-based contrast agents because of the unique magnetic
properties described in 1.2. Gadolinium chelates typically has a coordination number
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of 9, such as Gd (III)Cl3 hexahydrate, gadobutrol, and gadoteridol. In gadobutrol and
gadoteridol, there are eight coordinating ligands with an open available coordinating
site for water interaction. This limits biological interaction while keeping the metal ion
species soluble in polar media.
1.6 Objectives
It is the goal of this work to build off previous knowledge and construct an ionsensitive polymer MRI contrast agent using the knowledge of organic and polymer
chemistry. Many of these polymeric reactions in the following chapters are either free
radical polymerization or ionic reactions. With simple organic reactions such as SN2
reactions or click reactions. As well as extensive characterization techniques. Such as
nuclear magnetic resonance (NMR), Fourier transmission inferred spectroscopy
(FTIR), and Inductively coupled plasma mass spectrometry (ICP-MS). NMR after every
step of synthesis with the addition of FTIR for certain steps. Then the final product
gadolinium concentration was then tested using ICP-MS. As stated, before the primary
goal of this project is to create a polymeric contrast agent that could potentially detect
free calcium ions. Also, this aims to discuss the effect of molecular weight on the
relaxivity, T1, and T2 relaxation times of the polymeric contrast agent. To approach the
problem, we first started with a simple approach, which described in chapter 2.
Following a more advanced and controlled synthesis with the use of an already preestablished calcium-sensing chelator (BAPTA -AM), which is then conjugated on to a
polymer backbone, which described in detail in chapter 3.
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CHAPTER 2
Synthesis and characterization of Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris (acetic
acid) ethyl vinyl ether co maleic anhydride and analysis of MRI properties
2.1 Introduction
This chapter introduces one of the first approaches to create a polymeric MRI contrast
agent. In this work, a simple method was adopted. It was thought that if it was possible
to simplify the problem by constituting the polymeric contrast agent in two parts. A
“chelating” component and a calcium responsive component. Moreover, the product that
was needed to be synthesized had to a have at least readily accessible carboxylic acid
components to bind to the free calcium in the system. As well as the ability to modify the
polymer backbone as well. For this approach, we needed to select the monomers
carefully. Furthermore, the polymer that we needed to create also had the constraint of
being an alternating copolymer so that each carboxylic acid on the polymer backbone
could coordinate with the corresponding gadolinium ion. Conveniently there is one wellknown polymer that can fit this category. An alternating copolymer between vinyl ethers
and maleic anhydride is known to produce alternating copolymer (30, 31). For the
monomer selection, 2-chloroethyl vinyl ether and maleic anhydride were chosen as the
monomers. 2-chloroethyl vinyl ether is chosen because the vinyl chlorine group will
provide a means of functionalization to cognate the chelating molecule. Once the
molecule was chosen, the next decision is to pick a chelator component that we then
could couple with the polymer. The chelator should be modeled after already approved
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contrast agents such as Gadovist (gadobutrol) and ProHance (gadoteridol). This will allow
us to compare it to a known reference. This chapter will discuss the synthesis of this
polymeric contrast agent along with chemical, structural characterization, and its
potential use as an MRI contrast agent. Ultimately a chemical structure of the
corresponding polymer shown in figure 2.1 was chosen, and its possible interaction with
calcium will take place. As calcium comes into proximity to the polymer backbone, the
carboxylic acid will interact with calcium over coordinating with the gadolinium opening
two free water interaction sites. Effectively making it a calcium-sensing polymeric
contrast agent.

O
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Ca2+

O OO

O

O

n
O

N N
Gd
N N
O

O O

O

O OO

O

n

N N
Gd
N N

O
O

O O

O

Figure 2.1) Theoretical interaction with calcium and polymeric contrast agent with the
carboxylic acid group on the polymer backbone.
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2.2 Synthesis of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane)
(PDO3A)
The synthesis of PDO3A was followed following Jagardish et al. As shown in figure 2.2.
First, the cyclen(1,4,7,10-tetraazacyclododecane) was put into suspension with ten
equivalents of sodium acetate with dimethylacetamide (DMA) under an inert N2
atmosphere. Then three equivalents of t-butyl bromoacetate were dissolved in DMA.
Afterward, the cyclen sodium acetate suspension was then cooled down to -20 °C in an
acetone bath. Then the t-butyl bromoacetate solution was then added dropwise over 5
minutes in which then the solution was then allowed to reach room temperature and
continued stirring overnight. After 24 hours of stirring, water was then added into the
solution until a clear solution was observed with any solids that were then was filtered
out.
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Figure 2.2) Trialkylation of t-butyl bromoacetate with cyclen for the formation of ,4,7-tris(tertbutoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane) hydro-bromine.

The product was then extracted from the solution by adding sodium bicarbonate until the
crude product precipitated out of solution, which then was collected through vacuum
filtration. The crude product was then dissolved in chloroform and washed 3x with water
then dried with magnesium sulfate. The magnesium sulfate was then removed through
filtration, and the organic solution was reduced under vacuum before precipitating out
the cleaned product with the addition of diethyl ether. The product was then collected
after filtration. The product was then purified using silica gel chromatography with a
mobile phase of 10:1 dichloromethane (DCM) and methanol solution. The solution was
made by taking 500 ml of DCM and adding 50 ml of methanol. Silica gel was then added
to a glass chromatography column. The amount of silica was based on 20x the mass of
the crude product that was going to be purified. The first step was to put the silica into a
slurry with the DCM-methanol solution. After then it was added to the column. The about
1 column’s worth of DCM-methanol solution was then added with gently tapping the
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sides of the column to ensure compact packing. Afterward, just enough DCM-methanol
solution mixture was added to dissolve the crude product. It was then pipetted into the
column and allowed to dissipate through the silica. In which fractions were taken every
10 to 15 ml. The fractions were checked using an iodine stain on a TLC plate to examine
the product's elution time. After the fractions were collected, each was reduced under
vacuum, and an NMR was taken of each fraction. After examining the NMR of each
fraction, the purist fraction was collected and combined, which yielded the NMR spectra
in figure 2.3. The peaks corresponding at 1.4 are significant of the t-butyl esters, while the
peaks at 2.5 to 3.2 correlate to the cyclic ring, and the peaks 3.4 to 3.7 pertain to the
protons on the t-butyl ester arm located next to the nitrogen. Given the proton NMR was
able to identify each peak after purification is adequate proof that the reaction was
successful. Furthermore, the NMR proton chemical shifts are also consistent with the
literature values of the corresponding compound.
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Figure 2.3) NMR of 4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10tetraazacyclododecane) hydro-bromine.

After the POD3A salt was correctly characterized with NMR, cleavage of the HBr group
was then done using potassium bicarbonate in anhydrous acetonitrile with a temperature
of 50°C as described in Xiao Y, Paudel R, Liu J, Ma C, Zhang Z, Zhou S (5). Afterward, the
filtration of potassium bicarbonate was done; then, the organic solution was reduced
under vacuum until dry. In order to remove any residual base, it was then dissolved in
chloroform and washed with 3x times with water. After this, it was dried with magnesium
sulfate then reduced under vacuum to afford PDO3A, as shown in figure 2.4. The
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difference between the cleaved PDO3A oil and the PDO3A salt is the reduction of the peak
corresponding to 10ppm. As well as a change in physical properties, the PDO3A is just a
clear, viscous oil, while the PDO3A is a white powder.
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Figure 2.4) NMR of 4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane)

22

2.3 Synthesis of chloroethyl vinyl ether co maleic anhydride
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Figure 2.5) Scheme of radical polymerization of 2-chlorethylvinyl ether and
maleic anhydride.

An alternating copolymerization was done between 2-chloroethyl vinyl ether and maleic
anhydride, as shown in figure 2.5. The polymerization conducted as a free radical
polymerization using 2,2′-Azobis(2-methylpropionitrile) (AIBN) as the radical initiator.
This reaction was done in an inert environment where 1:1 molar equivalent of 2chloroethyl vinyl ether, maleic anhydride, and AIBN were added to a flask with the
addition of tetrahydrofuran (THF). The reaction was then allowed to go for 2 hours.
Afterward, the solution was then reduced under pressure. Then finally, the product was
precipitated the diethyl ether and collected through vacuum filtration. An NMR and FTIR
were then obtained and shown in figure 2.6 and figure 2.7 respectability.
In this proton NMR, the total integration came out to be 1644 protons yielding a
molecular weight of about 370 protons giving the approximate molecular weight of about
11,000 g/mol and about 72 repeat units. The molecular weight is done by normalizing the
NMR peak at 1.7 ppm as the AIBN starting unit and normalizing it to 12 protons because
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the termination mechanism is termination by disproportion for further structural
conformation, and FTIR analysis was also done. The FTIR analysis was able to identify all
functional groups in the polymer showing structural confirmation that the polymer was
successfully synthesized.
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2.4 Synthesis of modified 1,4,7,10-tetraazacyclododecane-1,4,7-tris(tertbutoxycarbonylmethyl) ethyl vinyl ether co Maleic anhydride (CEVE-co-MA)
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Figure 2.8) Scheme of modified 1,4,7,10tetraazacyclododecane-1,4,7-tris(tert-butoxycarbonylmethyl)
ethyl vinyl ether co maleic anhydride (CEVE-co-MA)
With the successful synthesis of both out polymer and out corresponding contrast
agent, now a simple Sn2 reaction can be used to react the secondary amine on the
PDO3A with the alkyl halide on the chloroethyl vinyl ether. For this, we react 1:1 molar
equivalent of our alternating copolymer and the POD3A with TEA under reflux for 24
hours. The solution was then precipitated in hexane and then purified using 7.5k
molecular weight dialysis tubing, after which the following NMR spectra and FTIR
spectra in figure 2.9 and figure 2.10 respectively. In this particular case, the following
NMR showed us the approximate molecular weights of 12,725 g/mol and was
determined similarly to how the method was done in section 2.3.
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Figure 2.10) FTIR of 1,4,7,10-tetraazacyclododecane-1,4,7tris(tert-butoxycarbonylmethyl) ethyl vinyl ether
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2.5 Synthesis of modified Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris (acetic acid)
ethyl vinyl ether co maleic anhydride
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Figure 2.11) Scheme of Modified Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris
(acetic acid) ethyl vinyl ether co maleic anhydride

The next step in our synthesis is a deprotection of the t-butyl esters groups into carboxylic
acids. Deprotection was done using trifluoracetic acid (TFA) in excess to cleave the t-butyl
ester into in carboxylic acid, after which gadolinium (III) chloride was added to for
chelation forming the corresponding structure. The product was then further put through
dialysis for two days, followed by lyophilization. The concentration of gadolinium in the
sample was then characterized using ICP-MS with the isotope of gadolinium that was
selected was Gd 157 as that was the most abundant isotope that provided no
interference. In order to make sure that we get the correct concentration, a sample of the
known amount was dissolved in a known amount of water in which it was pipetted into
different scintillation vials at different volumes. The solutions were then put into an oven
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for 24 hours at 500 °C to decompose the organic polymer. After 24 hours, there was no
observable matter in the glass scintillation vials. Then 15 ml of 2% w/v nitric was added
to the vials, which was then placed into 15 ml centrifuge tubes. The samples were then
taken to L.G. Rich Environmental Research Laboratory to have the samples analyzed
through ICP-MS.

2.6 MRI contrast properties of modified Gd- 1,4,7,10-tetraazacyclododecane-1,4,7-tris
(acetic acid) ethyl vinyl ether co maleic anhydride
The MRI analysis was done at the University of Alabama at Birmingham inside a 3
Tesla siemens MRI in which the department of neurology obtained the scan. The
experimental setup consisted of a bucket filled with water with our sample holder that
was then placed in a headspace coil, as shown in figure 2.12. In order to provide a better
signal to noise ratio, the water in the bucket had 10 ml of ProHance to shorten the T1 and
T2 of the background. The preparation of the samples was done by picking concentration
of polymer was picked at certain concentrations as well as the calcium levels such that
there were several chelate concentrations. These several concentrations were repeatedly
made, only changing the calcium concentrations. Our initial studies involved calcium
levels in the physiological range, such as 0 to 1.5 mM of calcium. While other studies show
calcium levels at different ranges. Moreover, the [Ca]/[COOH] was also compared.
Comparing the [Ca]/[COOH], in a way, gives some insight into how well this polymeric
contrast agent interacts with calcium. The sequencing for T1 and T2 was chosen through
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the University of Alabama, Birmingham. The T1 sequences involved TRs at 4 seconds and
predetermined IRs of 25, 50, 250, 500, 750, and 1200 milliseconds for the T1
measurements. The corresponding T2 sequence uses 32 TEs and a TR of 4 seconds to help
generate the T2 images. The T1 and T2 images were then used to create T1 and T2 maps
using MATLAB software.

Figure 2.12) Image of experimental set up with the sample holder inside a head space coil a
bucket filled with ProHance water surrounding the samples

Briefly, the T1 and T2 images are imported into MATLAB in which then each pixel on each
image undergoes an exponential curve fit, which is then exported out of MATLAB into a
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corresponding dicom image called either a T1 or T2 map. An example of mapping is
shown in figures 2.13 and 2.14, showing T1 and T2 mapping, respectively. Furthermore,
in the image of the T1 mapping shows how the relaxation times of T1 were obtained
through the exported dicom image. The software, RadiAnt, translates the pixel intensity
of each voxel and gives out a corresponding average T1 time with max, min, and
standard deviation over the area analyzed.

Figure 2.13) Example of T1 mapping with how to get the corresponding T1 vales of each
sample from the using RadiAnt as the software
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Figure 2.14) Example of T2 mapping
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Figure 2.15) T1 mapping of ProHance
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Figure 2.17) Graph of T1 vs calcium concentration for 0.25 mg/ml and 0.01666 mg/ml

Each T1 time was then recorded into an excel spreadsheet keeping note of the known
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polymer and calcium concentrations in each endorphin tube. However, before we
conducted the experiments one of the first experiments that were done was the use of a
known contrast agent for us to make comparisons and this is shown in figure 2.12, along
with figure 2.16 which indicates the relaxivity generated from figure 2.15
The selected contrast agent used was ProHance for comparison. The reason for
this is because of its structural similarity to the chelate component of our polymeric
contrast agent. The results indicate an R-squared value of 0.9485 with a linear slope of
2.3643 L/mmol S in deionized water. This compares similarly to the reported values of
ProHance of about 2.6 L/mmol S., Indicating that the MRI system acceptable to use for
quantitative measurements. The same was also done with Gadvist (gadobutrol) which is
another FDA approved contrast agent with known relaxation times and measurements
The results were then plotted in several ways to help better understand the data. First,
the T1 times were plotted as a function of calcium. Several plots are shown in graphs
2.14 that showed the attempt to demonstrate the effect that calcium had on the
system. Furthermore, an analysis was also compared with just DI water and samples of
ProHance to indicate if the MRI scanner was working as intended.
The sample of polymer concentration with corresponding values of 0.25 and 0.1666
mg/ml shows relatively flat dependence on calcium until the concentration approaches
one mM of calcium concentration. Then afterward, it is followed by a gradual increase
after calcium levels reach high elevation. What is also observed what appeared to be is
that as the concentration of polymer drops, the dip around 1mM becomes less and less
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pronounced. However, there is still a gap in the calcium levels that we are examining, so
further analysis is needed to exhibit this behavior. For this, a new series ran to help fill
the gap between the 0.6 mM and 0.8 mM. Unfortunately shows no indication of calcium
response. We then looked at the results more closely we thus, we did construct plots of
moles of Ca and moles of COOH as shown in graphs 2.18 for the 0.25 mg/ml series. In a
theoretical scenario, it would take one free calcium ion per 2 carboxylic acid giving a max
ratio of 0.5 [Ca]/[COOH] in an ideal case. When looking back previous literature on
calcium-sensing ions such as Angelovski et al., work his macromolecule seemed to
demonstrate a similar effect with the shortest T1 time being around 2 [Ca]/[polymer
concentration] or about 1 [Ca]/[COOH] (21). Looking back at other literature, examples
such as the publication of the work of a Barandov et al. showed his molecules have a
[Ca]/[COOH] of around 1 to 1.5, both demonstrating where the onset where his relaxivity
curve starts to behave asymptotically. Leading to suggesting
evidence that a [Ca]/[COOH] ratio of around 1 to 1.6 indicate that once the
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Figure 2.18) Graph of T1 vs [Ca]/[COOH] for 0.25 mg/ml chelate

0.333 mM [Ca]
1.1666 mM [Ca]

1000

T1 (ms)

800

600

400

200

0.0

0.1

0.2

0.3

Polymer concentration (mg/ml)

Figure 2.19) Graph of T1 vs constant calcium levels of 0.3333 and 1.6666 calcium
concentration at 0 mM and 0.0833 mM of free calcium with R-squared
values of 0.59 and 0.77 respectively
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Macromolecules are saturated with calcium. The T1 values and relaxivity values do not
change very much. It is shown that we didn’t exhibit the same dependency, as shown in
graph 2.18. Instead, a relativity flat line between T1 and Ca/COOH indicating that the is
no observable behavior between T1 and the ratio between Ca/COOH. Potential reasons
for this could be simply of structural repeat unit is simply not robust enough. To further
elaborate previous literature uses BAPTA modified macromolecules, which provide two
advantages. The first is that this molecule consists of four carboxylic acid groups readily
available to bind the calcium as opposed to two.

0mM[Ca]
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0.3
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Figure 2.20) Graph of T1 vs Constant calcium levels of 0 and
0.08333 calcium concentration at 0 mM and 0.0833 mM

The next is that the backbone on our polymer contains a rather ridged carboxylic acid
group. This means that the spatial conformation is limited to that of BAPTA and thus can
lower binding affinity to free calcium ions. Other possibilities may suggest that since the
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product was imaged in DI water, that it may not have a strong enough binding affinity to
the calcium ions due to it being a close to neutral pH. This idea was, however, partially
investigated. The pH of the solution was measured by both pH paper and pH probe, with
only slight differences examined between the two. Overall, the pH of the solution was
found to be about 7.3, which is a slightly basic environment. However, the samples were
prepared at different concentrations at constant calcium levels. This is shown in figures
2.20 at was shown here is the comparison of the R squared values and the linear
equations. What is shown is that at low calcium levels, the equation that is referenced in
chapter one, equation 1, proves to be true. However, if the calcium levels increase, the
linearity in the curves starts to shift, showing no significant relationship between polymer
concentration and the relaxation time. The results demonstrate that it shows not only T1
change but that linear relationship between the concentration of gadolinium and the
observed relaxation rates also change with varying levels of calcium concentration. In
exaggeration, the linear constant [R1] shown in equation 1 to give an idea of how effective
other contrast are no longer become a valid form of measurement for this contrast
agent—indicating a possible way that calcium levels influence the system our polymer
water interaction. We also wanted to examine how our polymer played a role in T2. As
shown in figures 2.21 what was discovered was that the T2 curves showed similar results
as T1 and that the only significant difference is that the relaxation times for T1 are great
than the relaxation times for T2 meaning that T2 is always shorter than T1 and this is to be
expected in all cases for MRI measurements. The effect of T2 shorting can be attributed
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to the fact that these are macromolecules that pose a heavy influence on T2. The
mechanism is the slowing water protons rotation and diffusion processes.
Moreover, this could also exemplify the effect of the hydrogen bonding between our
polymer backbone and the free water protons, and this will also start to reduce T2 times.
Only three considerations attribute to this effect. The first is the size of the particle. The
second is the concentration, and lastly is the types of functional groups the polymer is
composed of (32-34). However, for graph 2.23, there is not an obvious correlation
between [Ca]/[COOH]. The reason could be due to the already short T2 times that are
examined—thus making the results having a baseline effect.
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Figure 2.21) Graph of T2 vs Calcium Concentration for 0.25 mg/ml
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2.7 Potential error in measurements
As stated in this work, the T1 and T2 mappings were done through a MATLAB code.
However, original mapping was done through Siemens using their software, and what was
discovered was that each sample varied in T1 mappings by about 300ms. How the
mapping was generated can attribute to this effect. A stated before IR times of 25, 50, 75,
100, 250, 500, 750, 1000, and 1200 were conducted. However, the siemens software only
takes two IR times for analysis, while our MATLAB code makes all the IR times to generate
the mappings. We believe that since our map was constructed with more data points that
it is more accurate to the actual T1 times as opposed to the siemens software. In terms of
the T2 analysis, there was a little discrepancy with the mappings. This is likely because,
just like the Siemens software, our MATLAB code takes into account all the echo times
(TE), and thus the measurement is similar. Further investigation should be done to get the
measurements more in accordance since this is for quantitative use. Nevertheless, the
trending from the measured T1 and T2 are similar regardless of software and that these
only affect just the measured T1 and T2 relaxation times. Thus the trend from reach graph
represented in the chapter is still valid.
2.8 Dynamic light scattering measurement
Dynamic Light scattering measurements (DLS) were done on the samples varying in pH as
well as calcium concentration to attempt to understand why no significant calcium
response was observed. In previous literature Thomas Swift, Linda Swanson, a Mark
Geoghegan, and Stephen Rimmer examined global to coil transitions based on the varying
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effects of pH for polyacrylic acid(35). As shown in there study, the pH affects the
molecular weight showing that a pH of a more acidic solution provided a more globular
shape. In contrast, a higher pH produced a more linear chain conformation in their
experiment. Furthermore, other studies also show that if pH changes with copolymers of
N-isopropyl acrylamide, they also examine this coil to globular transition as pH was
changed (36). Due to the nature of theses polymer to be able to carry charges species on
their backbone. What was hypothesized is that our polymer showed aggregation. This
could explain why there was shown no calcium response in the polymer. The exaggeration
would not allow into the polymer backbone and thus limiting the calcium sensitivity of
the polymer. For this, a light scattering experiment was conducted with the results
located in appendix A.1 As shown in the results, the pH of the first polymer solution in DI
showed a size of about 700 nm in diameter. Afterward, calcium chloride was added to
adjust the calcium level in the sample to 0.5 mM, then 1mM, as shown the overall change
in diameter, did not change very much, which suggests that calcium has little influence
on the system. Then the pH was adjusted on the polymer system to see how that
influenced the size measured by DLS. For this, the pH was adjusted to 1 and 14. What was
shown in both ways that the DLS measurements showed a slight increase in particle size
to 1200 nm in size. In all experiments, the measurements of the particle sizes proved to
be quite large, perhaps indicating that there is aggregation forming from our particles,
and that is why there is no calcium response as opposed to a globular conformation. Our
size Also, the system may show a slight sensitivity to pH. Previous literature indicates that
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DLS measurements for polyethylene glycol in the work of Nelson and Cosgrove
demonstrated that PEG, a high molecular weight (1,000,000 g/mol), had a 10 nm
hydrodynamic diameter(37). Furthermore, pertaining to the work of Melinda, Bodar,
Hartmann, and Borbely, it was demonstrated that polyacrylic nanoparticles crossed linked
gave a hydrodynamic diameter of 120nm (38). Similar work in Zhenyuan Qu, Fenglin Hu,
Kaimin Chen, Zongqiang Duan, Hongchen Gu, Hong Xu conducted DLS measurements on
their colloidal particles with a max measurement of 500nm (39). Since the DLS
measurements around are samples, indicate at size on the order of 0.7 to 1.2 microns
leads evidence to suggest that the polymer contrast agent is forming aggregation and thus
is starting to represent measurements like a colloidal suspension as opposed to a dilute
polymer solution. Working through calculations for the dynamic size of the polymer using
the equation Rh =K Mw(a) (3) where Rh is the hydrodynamic radius, K is a proportional
constant, Mw is the molecular weight, and a can range from 0.5 to 3/5 depending on if
the solvent is a good solvent or not. In our case, we will use an estimation based on the
parameters of PEG, K = 0.145, and a = 0.571(40). In our case of this polymer, our
hydrodynamic diameter is calculated to be 57.9 nm in hydrodynamic diameter. Moreover,
an alternative way to calculate hydrodynamic diameter is us using the following equation
(Rh= KT/(3 π (μ)D)) (4) Where K is the Boltzmann constant, T is the absolute temperature,
μ is the viscosity and D is the translation diffusion coefficient. In our case, we will use
Abohachem Laguecir Serge Ulrich, Jerome Labille, Nicolas Fatin-Rouge, Serge Stoll,
Jacques Buffle with polyacrylic acid to approximate the hydrodynamic diameter of our
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polymer using a diffusion coefficient of 0.4(cm2/s*1x106)(41). After numerical calculation,
the resulting hydrodynamic diameter is 1.2 nm in size. In both theoretical calculations, our
measurement is much larger. Therefore, this provides some evidence to support that we
do have aggregation.
2.9 Conclusions
Inconclusion, a successfully synthesized polymeric contrast agent, was made and
characterized through FTIR and NMR along with each step that was characterized through
NMR and FTIR. The magnetic resonance imaging measurements show that there is no
noticeable change in T1 times vs. calcium. Therefore, there is no noticeable change in R1
rates versus calcium since in two a reciprocal of each other. However, the linear linearity
of the T1 vs. chelate concentration does change as calcium levels are changed, giving this
some potential to be still used.
Conclusively, results seem to indicate no changes in response to calcium other
than the shift of linearity. The progress made here gives a good insight into why chapter
three is so important for the future of ion sensing contrast agents. Further investigation
is still needed to understand its lack of calcium responsivity. In chapter 3, the approaches
made will help rectify some of the potential issues in chapter 2 as it takes more of a similar
approach from literature.
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CHAPTER 3
Potential improvement of first design using controlled polymerization
3.1 Introduction
The results from chapter 2 indicate some potential for an ion sensing polymeric contrast
agent. However, this initial design is not without its flaws. One of the first issues of the
polymeric contrast shown in chapter 2 in the control of molecular weight since it is a free
radical polymerization its disparities can vary and provide a wide range of molecular
weights. This, in turn, could affect some of the MRI contrast properties that were also
shown in chapter 2. Furthermore, common calcium chelating agents, as stated in chapter
1, such as EDTA or BAPTA, have four carboxylic acid groups as opposed to our two
carboxylic acids for the structure in chapter 2. Lastly, our polymer structure in chapter 2
may not be selective towards just calcium ions but may be susceptible to other divalent
ions such as magnesium. This chapter aims to examine an alternative polymeric contrast
agent that aims to address some of the issues with the structure in chapter 2. For this
approach, we wanted a controlled polymerization for finely controllable molecular weight
as well as the use of a calcium dye (BAPTA), which has been proven to a great calcium
chelator over other competing ions. For this, we have proposed two synthetic pathways
that have the potential to lead to the final product, as shown in Figure 3.1. In each
pathway involved is a controlled ionic polymerization. The first path was to construct a
polymer then modify the polymer with two potential function groups for this reaction
strategies were taken out of the work of Kim, Kweon, and Noh using BF3 (OEt)2 as the
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initiator(42). The next one involves monomer synthesis then polymerizing at the end to
produce our statistical copolymer. For this, we try modifying our epoxide ring with a ringopening using either a primary or secondary amine. Then later, a ring-closing reaction is
done to reform the epoxide ring. The ring closed product could then be polymerized. This
strategy constructed created from examples listed by Saddique et al. 2016 (43).
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Figure 3.1) Image of repeat unit structure of new repeat unit using ether
backbone that is both modified with BAPTA-AM and PDO3A.
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3.2 Nitration and reduction of BAPTA
The nitration of BAPTA was done by dissolving BAPTA in dimethyl sulfoxide then added
1.5 equivalent of sulfuric acid with 1.5 equivalents of nitric acid over dropwise into the
flask contain DMSO-BAPTA solution at room temperature. Then the reaction could stir
overnight. The reaction scheme can be shown in figure 3.2. Afterward, the product in
DMSO underwent lyophilization to remove DMSO, water, and acid from the solution. The
carbon 13 NMR was done for structural identification. Then the nitrated BAPTA was
dissolved in DMSO with the addition of Pd/C, which was then allowed to stir overnight in
the open air. This process allowed for the reduction of the nitro group into a primary
amine. The full reaction is as follows, the nitrated BAPTA (n-BAPTA) was added to a 50 ml
flask was added to in with ethanol at room temperature. Then the Pd/C catalyst was
added to the solution in 50 mg/mmol of substrate. The hydrogen gas was produced by
dripping methanol into a suspension of sodium hydride and hexane and routed such that
the hydrogen gas was able to bubble through the reaction solution. This reaction
proceeded for 40 minutes before the reaction was stopped. The full reaction setup can
be seen in the appendix A.2.
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Figure 3.3) Theoretical reaction scheme starting with polymer synthesis
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In this pathway, we first take t-butyl alcohol and react it with BF3(OEt)2 with the addition
of epichlorohydrin. The process is named a cationic polymerization reaction. The
monomer and initiator ratio was picked, such that the target molecular weight is 10,000
g/mol. This was done by using the following procedure described in Kim, Kweon, and
Noh's work(42). Briefly, BF3(OEt)2 was added to a 250 ml flask, which was then put under
vacuum. Then dry dichloromethane was then added to the flask. Afterward, the addition
of epichlorohydrin was added dropwise to the flask at room temperature. The reaction
was then allowed to react overnight, then was reduced under pressure and then
precipitated in hexane. The product was then collected and analyzed. Using NMR, FTIR,
and GPC. The NMR showed in figure 3.4 indicates the presence of an ether backbone and
the presence of the end group. The FTIR shown in figure 3.5 had shown the indicated
functional groups, while the GPC shown in figure 3.6 showed the molecular weight was
low compared to polystyrene samples. The peak area of the lowest standard using the RI
dictator is 436 in figure 3.6, with our sample peak being 11.1, as shown in figure 3.7. This
indicates that we have the formation of oligomers, which is evidence to suggest that the
reaction was terminating early the potential issues for this could be the water in the flask
at the time of the reaction or potential branching repeat units causing the reaction to
terminate early. Further investigation is required; however, it does show early signs of
success.
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Figure 3.4) Proton NMR of PECH polymer

Figure 3.5) FTIR of PECH showing formation of ether backbone and halogen
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Figure 3.6) Polystyrene GPC standards going from 500 to 99,000 g/mol

Figure 3.7) GPC elution of the sample showing 11.151 as g/mol as molecular weight by polystyrene
standards

51

The next step of the process is to react the PDO3A as synthesized in chapter 2 with the
chlorine in 0.5 molar equivalent using some base to help the nucleophilic attack then
react the primary amine on the BAPTA with the other 0.5 molar chlorine of the
epichlorohydrin. Then following similar procedures in chapter 2 for deprotection, react
the polymer with trifluoracetic acid in 3 molar equivalent for 24 hours followed by
evaporation of the acid in which an NMR and FTIR should then be taken. Finally, the last
step should be to chelate with gadolinium (III) chloride hexahydrate for at least 24
hours, followed by a purification process and characterization of ICP-MS.
3.4 Pathway number 2
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Figure 3.8) Second proposed pathway for synthesis 2.0
The second pathway involves synthesizing the monomer first before the polymerization
the advantages of this is that the reaction can either be cationic or anionic polymerization.
For this, nitration and reduction of the BAPTA is needed to be as shown in 3.1. Afterward,
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the addition of BF3(OEt)2 was added in 1:1:1 molar equivalent of the POD3A and the
Epichlorohydrin under an inert atmosphere at 55 °C. The reaction was done in the
following steps. First, the flask was flamed dried and purged with nitrogen, then BF3(OEt)2
and Epibromohydrin was added to the flask with 10 ml of dichloromethane and was
allowed to stir for 20 minutes at 55 °C. After this, a solution of PDO3A in 10 ml of
dichloromethane was added dropwise into the flask and allowed to stir overnight. This
reaction will force a ring-opening reaction, thus successfully modifying our PDO3A on to
our substrate. Afterward, the reaction was then reduced under pressure and precipitated
in hexane. As shown in the FTIR after purification, the presence of the carbonyl that is
only presence on the PDO3A is still there as well as the presence of a hydroxyl group. This
evidence suggests that there was a successful ring-opening reaction and that the EPI
bromohydrin was successfully modified with the PDO3A chelating species. Followed after
the FTIR and NMR analysis was conducted, as shown in figure 3.9, the presence of the tbutyl esters protecting group, which also indicates that there was a successful ringopening reaction and that the secondary amine on the PDO3A was successfully converted
into a tertiary amine.
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Figure 3.9) NMR of Ring opened product of PDO3A with Epibromohydrin

Figure 3.10) FTIR of ring opened product of PDO3A with Epibromohydrin.
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In this case, both the NMR and the FTIR are in agreement with the ring-opening
reaction.
Afterward, the product was then treated with sodium hydride in 1.5 molar excess. The
sodium hydride will deprotonate the oxygen and force the intramolecular ring-closing
reaction. The reaction was done at 50°C overnight. In which the product was then
reduced under pressure and precipitated in hexane. Then an FTIR was taken of the
product as shown in figure 3.9 there an OH stretch peak at 3500 wave number after the
ring-opening reaction and then after the reaction with sodium hydride as shown in
figure 3.9 there is no longer any OH stretch at 3500 wave number indicating that the
was removal of the hydroxyl group showing that the reaction was then ring closed.
A similar reaction is done with the primary amine on the BAPTA and BF3(OEt)2 with the
epichlorohydrin. Afterward, the two monomers would then be copolymerized using an
anionic initiator of potassium bis trimethylsilyl amide would be used. It was chosen
because of its ability to easily be disquisition NMR as well as its ability to be reduced to a
primary amine after treatment with an acid such as trifluoroacetic acid. This provides it
with more functionality for potential later uses. The potential reaction scheme is shown
in figure 3.12
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Figure 3.12) Proposed anionic reaction for pathway two done with the two-monomer synthesis
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3.4 Discussion and future work
The goal of chapter 3 was to provide two particular synthetic pathways for potential
improvement from the theory derived in chapter 2. There are still some issues with each
synthetic route to work out its optimal workup and reaction conditions. The most
promising route so far has been the synthesis of the monomer before polymerization.
This is likely since this reaction is not as water sensitive as the cationic polymerization.
The FTIR before and after the ring-opening and ring-closing does show changes in the FTIR
around 3500 wavenumbers showing the loss of alcohol peak. Showing evidence that the
ring-closing reaction was successful. This potentially shows epoxide ring formation after
reaction with sodium hydride. Also, the same reaction ring opening followed by a ringclosing reaction for after the nitration of the BAPTA-AM calcium chelator accurately
synthesized and characterized with FTIR and NMR.
Moreover, for future work, the polymerization of the two monomers should also
be done with reaction conditions yet to be determined likely plans for to perform the
reaction at -20 °C followed by a workup and then an NMR and FTIR of the final product.
As well the deprotection of the t-butyl groups on the polymer backbone and chelation
with gadolinium (III) chloride hexahydrate further needs to be done, as well as purification
and characterization of how much gadolinium should be analyzed by ICP-MS. Finally, an
analysis of its MRI properties needs to be conducted. The study should be like how the
polymeric contrast agent in chapter 2 should be done.
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CHAPTER 4
Conclusion and future work

4.1 Conclusion
All synthetic work has been successful and characterized by FTIR and NMR
spectroscopy. However, the application for the designed structure in chapter 2 did not
work as intended. This is still a step in understanding how ion sensing chelates. From the
data, it was concluded that a more robust polymeric contrast agent is needed to probe
the free calcium ions. Which still leads to needing development in chapter 3. The new and
proposed polymeric contrast agent is more in line with how current literature approaches
this problem.
The fundamental difference is that in chapter 2 the polymer synthesized consists
of 2 carboxylic acids groups per repeat unit and is a quite rigid structure and the polymer
designed mentioned in chapter three shows great promise as it also addresses these
issues as well in the sense that it builds off already established calcium-sensing chelates
more specifically BAPTA-AM. As mentioned, the cationic reaction in chapter 3 caused
early termination likely due to the presence in the water. The ring-opening approach,
then the ring-closing approach, provides a better synthetic route. This is because
purification of the monomers can be conducted after the reaction then the
polymerization can be done afterward. This would seem to provide better control over
the synthesis and properties.
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In conclusion, the polymeric structure in the chapter was successfully synthesized and
characterized as well as the MRI properties examined as well as its effects of calcium on
the polymeric structure. The ring-opening and ring-closing rection in chapter 3 was
successfully carried out and characterized through FTIR and NMR.

4.2 Future work
In chapter 2 of this work, more information needs to be gathered on the nonchelating water-soluble polymer in order to further help establish the meaning of the
DLS results. Such as synthesizing and producing polyacrylic acid or polymethacrylic acid
and copolymerization of polyacrylic acid with maleic anhydride or copolymerizing
polymethacrylic acid with maleic anhydride. Also, a more in-depth scattering study
could be done such as small-angle x-ray scattering or static light scattering
Work that currently needs to be done is the predominantly from chapter 3. Such
polymerization of the ring closed EPI-PDO3A hydrin, as mentioned in and the EPIBAPTAhydrin, as mentioned in 3.2. Future work also includes successful polymerization into a
statistical copolymer afterward, the deprotection of the protecting groups of the needs
to be done using trifluoracetic acid followed by a workup and characterization using FTIR
and NMR. Afterward, a Chelation using gadolinium (III) chloride hexahydrate allowing at
least 24 hours for reaction in methanol. Finally, the characterization of the amount of
gadolinium can be done using ICP-MS after dialysis to remove any remaining ions.
Afterward, samples should be made in the physiological range of calcium between 0 and
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1.5 mM with polymeric contrast ranges based on the results of the ICP-MS. Then finally,
the same analysis done for chapter 2 can be done for chapter 3. Moreover, depending on
the resulting test should be implemented to see how biocompatible the material is.
In terms of analysis development of MATLAB software was done to produce the
T1 and T2 mappings of the samples. Still, when compared to the MRI software for mapping,
it results varied in measurements meaning that there is an error in the measurement, and
this needs to be further studied to reconcile the difference, and perhaps a better
approach for how the mapping is made using MATLAB should also be further investigated.
Furthermore, in addition to the use of chapter 3 the can further built on using
other calcium chelators such as FURA-2 as another potential modifier to our functional
polymeric chelator due to its high affinity and ability to fluoresce under UV light gives an
idea for a new candidate that could be both MRI sensitive and multifunctional (44).
Moreover, what hasn’t yet been answer adequately in the thesis is the effect of
molecular weight on both relaxation and ion sensitivity. After the work proposed in
chapter three is done, it is recommended that several molecular weights be produced
followed by an MRI study and then compare the relaxation times the relxativity constant
of each contrast agent to see if there is a difference.
Furthermore, the biocompatibility of either product of chapter 2 or chapter 3 has
yet to be tested. Thus a series of tests need to be done to see how compatible they are
with biological systems, as well as studying the diffusion rates of the polymer throughout
the body.
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Appendix A.1- DLS size analysis in diameter of each sample
modification

Appendix A.2- Set up of reaction for hydrogenation of n-BAPTA with hydrogen
production reaction on the right and bubbling into reaction vessel on the left
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